Skip to main content
SpringerLink
Log in

Atorvastatin–Green Tea Interaction: Possible Mechanisms are Complicated, But Clinical Relevance is Not?

  • Letter to the Editor
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

The Original Article was published on 29 January 2020

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abdelkawy KS, Abdelaziz RM, Abdelmageed AM, Donia AM, El-Khodary NM. Effects of green tea extract on atorvastatin pharmacokinetics in healthy volunteers. Eur J Drug Metab Pharmacokinet. 2020. https://doi.org/10.1007/s13318-020-00608-6.

    Article  PubMed  Google Scholar 

  2. Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther. 2006;80(6):565–81.

    Article  CAS  Google Scholar 

  3. Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res. 2005;22(1):11–23.

    Article  CAS  Google Scholar 

  4. Kantola T, Kivisto KT, Neuvonen PJ. Effect of itraconazole on the pharmacokinetics of atorvastatin. Clin Pharmacol Ther. 1998;64(1):58–65.

    Article  CAS  Google Scholar 

  5. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin Pharmacol Ther. 1999;66(2):118–27.

    Article  CAS  Google Scholar 

  6. Seden K, Dickinson L, Khoo S, Back D. Grapefruit-drug interactions. Drugs. 2010;70(18):2373–407.

    Article  CAS  Google Scholar 

  7. Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res. 2001;479(1–2):197–206.

    Article  CAS  Google Scholar 

  8. Misaka S, Kawabe K, Onoue S, Werba JP, Giroli M, Tamaki S, et al. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet. 2013;28(3):244–9.

    Article  CAS  Google Scholar 

  9. Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, et al. Overview of green tea interaction with cardiovascular drugs. Curr Pharm Des. 2015;21(9):1213–9.

    Article  CAS  Google Scholar 

  10. Morse BL, Alberts JJ, Posada MM, Rehmel J, Kolur A, Tham LS, et al. Physiologically-based pharmacokinetic modeling of atorvastatin incorporating delayed gastric emptying and acid-to-lactone conversion. CPT Pharmacomet Syst Pharmacol. 2019;8(9):664–75.

    Article  CAS  Google Scholar 

  11. Misaka S, Yatabe J, Müller F, Takano K, Kawabe K, Glaeser H, et al. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin Pharmacol Ther. 2014;95(4):432–8.

    Article  CAS  Google Scholar 

  12. Abe O, Ono T, Sato H, Muller F, Ogata H, Miura I, et al. Role of (–)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers. Eur J Clin Pharmacol. 2018;74(6):775–83.

    Article  CAS  Google Scholar 

  13. Knauer MJ, Urquhart BL, Meyer zu Schwabedissen HE, Schwarz UI, Lemke CJ, Leake BF, et al. Human skeletal muscle drug transporters determine local exposure and toxicity of statins. Circ Res. 2010;106(2):297–306.

    Article  CAS  Google Scholar 

  14. Mandery K, Bujok K, Schmidt I, Keiser M, Siegmund W, Balk B, et al. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol. 2010;80(11):1746–53.

    Article  CAS  Google Scholar 

  15. Lau YY, Huang Y, Frassetto L, Benet LZ. Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Ther. 2007;81(2):194–204.

    Article  CAS  Google Scholar 

  16. Guo CX, Pei Q, Yin JY, Peng XD, Zhou BT, Zhao YC, et al. Effects of Ginkgo biloba extracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices. Xenobiotica. 2012;42(8):784–90.

    Article  CAS  Google Scholar 

  17. Yue M, Yang J, Jin M, Steiert B, Xiang Y, Zhang H, et al. Gly45 and Phe555 in transmembrane domains 1 and 10 are critical for the activation of organic anion transporting polypeptide 1B3 by epigallocatechin gallate. J Agric Food Chem. 2019;67(32):9079–87.

    Article  CAS  Google Scholar 

  18. Roth M, Timmermann BN, Hagenbuch B. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos. 2011;39(5):920–6.

    Article  Google Scholar 

  19. Zhang Y, Hays A, Noblett A, Thapa M, Hua DH, Hagenbuch B. Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives. J Nat Prod. 2013;76(3):368–73.

    Article  CAS  Google Scholar 

  20. Kearney AS, Crawford LF, Mehta SC, Radebaugh GW. The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981. Pharm Res. 1993;10(10):1461–5.

    Article  CAS  Google Scholar 

  21. Jacobsen W, Kuhn B, Soldner A, Kirchner G, Sewing KF, Kollman PA, et al. Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin. Drug Metab Dispos. 2000;28(11):1369–78.

    CAS  PubMed  Google Scholar 

  22. Narwal R, Akhlaghi F, Asberg A, Hermann M, Rosenbaum SE. Development of a population pharmacokinetic model for atorvastatin acid and its lactone metabolite. Clin Pharmacokinet. 2010;49(10):693–702.

    Article  CAS  Google Scholar 

  23. de la Pena A, Cui X, Geiser J, Loghin C. No dose adjustment is recommended for digoxin, warfarin, atorvastatin or a combination oral contraceptive when coadministered with dulaglutide. Clin Pharmacokinet. 2017;56(11):1415–27.

    Article  Google Scholar 

  24. Reddy P, Ellington D, Zhu Y, Zdrojewski I, Parent SJ, Harmatz JS, et al. Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily. Br J Clin Pharmacol. 2011;72(3):434–41.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan

    Shingen Misaka & Kenju Shimomura

Authors
  1. Shingen Misaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenju Shimomura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shingen Misaka.

Ethics declarations

Funding

No source of funding was used to prepare this letter.

Conflict of interest

Authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Misaka, S., Shimomura, K. Atorvastatin–Green Tea Interaction: Possible Mechanisms are Complicated, But Clinical Relevance is Not?. Eur J Drug Metab Pharmacokinet 45, 423–425 (2020). https://doi.org/10.1007/s13318-020-00620-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-020-00620-w

Search

Navigation